Our Mission: Restore Normal Rhythm to People Suffering From Atrial Fibrillation
AF is the most common cardiac arrhythmia. In US and EU over 9 million people are affected. AF contributes to more 80,000 deaths in the US alone.
That's a problem.
A problem that costs the US $7 billion and the EU $16 billion in direct care. Current treatments fall short with limited lasting effect and serious side effects.
AF is one of the largest unmet clinical needs of our time
Despite the great cost in suffering, lives and dollars, physicians still lack an effective cure or long-term palliative treatment for the symptoms and sequelae of atrial fibrillation. Existing therapies for the treatment and management of atrial fibrillation are limited, by either their long-term effectiveness or their adverse side effects or both. Side-effects of current treatments for atrial arrhythmias are pronounced, including the toxicity of antiarrhythmic drugs, burns related to external cardioversion, pain associated with atrial defibrillation and the irreversible scaring caused by cardiac ablation and surgery.